Issue navigation
Volume 39, Issue 5, May 2024
EDITORIAL
EULAR 2023 recommendations for SLE treatment: synopsis for the management of lupus nephritis: the European Renal Association–Immunonephrology Working Group (ERA-IWG) perspective
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 727–730, https://doi.org/10.1093/ndt/gfad230
Using genomics to understand severe COVID-19
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 731–734, https://doi.org/10.1093/ndt/gfad262
Maintaining kidney replacement therapy during armed conflicts
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 735–738, https://doi.org/10.1093/ndt/gfad259
Does it matter how we measure urinary creatinine in patients taking SGLT2 inhibitors?
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 739–741, https://doi.org/10.1093/ndt/gfae007
REVIEW
Shared decision making in elderly patients with kidney failure
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 742–751, https://doi.org/10.1093/ndt/gfad211
Endothelial to mesenchymal transition in kidney fibrosis
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 752–760, https://doi.org/10.1093/ndt/gfad238
Cell–cell communication in kidney fibrosis
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 761–769, https://doi.org/10.1093/ndt/gfad257
TREATMENT STANDARD
Anaemia in CKD—treatment standard
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 770–777, https://doi.org/10.1093/ndt/gfad250
ORIGINAL ARTICLE
How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 778–787, https://doi.org/10.1093/ndt/gfad214
Twenty-four-hour urine oxalate and risk of chronic kidney disease
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 788–794, https://doi.org/10.1093/ndt/gfad221
Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intake
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 795–807, https://doi.org/10.1093/ndt/gfad220
Early progression of chronic histologic lesions in kidney transplant biopsies is not associated with HLA histocompatibility
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 808–817, https://doi.org/10.1093/ndt/gfad246
Statin therapy and the incidence of atherosclerotic cardiovascular events after kidney transplantation
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 818–829, https://doi.org/10.1093/ndt/gfad217
Insomnia in patients on incident maintenance dialysis and the risk of major acute cardio-cerebrovascular events and all-cause mortality
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 830–837, https://doi.org/10.1093/ndt/gfad231
Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 838–847, https://doi.org/10.1093/ndt/gfad239
A new approach for cognitive impairment pattern in chronic kidney disease
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 848–859, https://doi.org/10.1093/ndt/gfad244
Intraindividual difference in estimated GFR by creatinine and cystatin C, cognitive trajectories and motoric cognitive risk syndrome
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 860–872, https://doi.org/10.1093/ndt/gfad234
Urinary peptide analysis to predict the response to blood pressure medication
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 873–883, https://doi.org/10.1093/ndt/gfad223
RESEARCH LETTER
Utility of 2-year Kidney Failure Risk Equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 884–887, https://doi.org/10.1093/ndt/gfad263
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 888–892, https://doi.org/10.1093/ndt/gfae005
Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern
Nephrology Dialysis Transplantation, Volume 39, Issue 5, May 2024, Pages 893–895, https://doi.org/10.1093/ndt/gfae012
